Filmmaker Dibakar Banerjee has faced numerous obstacles and setbacks in his professional career, from facing delays with his first film to watching his latest project, LSD 2, get unexpectedly pulled from release. In a recent interview, he revealed the difficulties he faced in getting Khosla Ka Ghosla released and the toll it took on his mental health. Despite finding success with UTV picking up his cult classic film, he continued to face unpredictable obstacles with his multi-film deal with Yash Raj Films, including a film being released without any marketing or his knowledge. Banerjee's story sheds light on the challenges and struggles faced by outsiders in the entertainment industry.
Balaji Motion Pictures and Cult Movies bring back the cult sensation with "Love Sex Aur Dhokha 2". Set in the era of hidden cameras, this sequel delves into the complexities of modern-day relationships in the internet age. Featuring a star-studded cast and helmed by director Dibakar Banerjee, this film promises to shock and intrigue audiences with its bold and gripping content. Scheduled to release on April 19, 2024, "Love Sex Aur Dhokha 2" is a must-watch for all lovers of intense and thought-provoking cinema.
GC Biopharma, a South Korean biopharmaceutical company, presented updates on their development of LSD treatments at the WORLDSymposium 2024 in San Diego. The company discussed the Phase III clinical trial results of their Hunter syndrome treatment and shared posters on the non-clinical results of treatments for Sanfilippo syndrome type A and Fabry disease. These developments are significant as LSDs, a group of rare genetic disorders, have limited treatment options and a high prevalence in South Korea.